Article
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and receptors in type 1, type 2 and type 17 inflammation in cross-sectional asthma study.
Thorax - 1 Sept 2020
Marks Michelle, Steele Chad, Moore Wendy C, Meyers Deborah A, Rector Brian, Ampleford Elizabeth, Bleecker Eugene R, Hastie Annette T
Abstract excerpt
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) reportedly promotes, or conversely, resolves inflammation in asthma. In this study of TRAIL and cell receptors in sputum, bronchoalveolar lavage and biopsy from subjects in the Severe Asthma Research Program at Wake Forest, the high TRAIL group had significant increases in all leucocytes, and was associated with increased type 1, type 2 and type 17...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.